CRO Icon has completed its previously announced acquisition of Aptiv Solutions.

Aptiv Solutions is a provider for the design and execution of adaptive clinical trials for pharmaceutical and biotech customers. The company also has in-depth experience in the management of medical device trials and its Japanese subsidiary, Niphix, is a full-service, oncology-focused CRO serving both Japanese and international customers.

“Aptiv’s adaptive trial capabilities, combined with our existing technology platforms, such as ICONIK and Firecrest, will further differentiate our services and help our customers take time and cost out of the development process,” said Nuala Murphy, president, Icon Clinical Research Services. “Their presence in Japan and medical device capabilities also will broaden our offerings in these markets.”